Unknown

Dataset Information

Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol.


ABSTRACT:

Introduction

Vulvovaginal candidiasis (VVC) is frequent in women worldwide and usually responds rapidly to topical or oral antifungal therapy. However, some women develop recurrent vulvovaginal candidiasis (RVVC), which is arbitrarily defined as four or more episodes every year. RVVC is a debilitating, long-term condition that can severely affect the quality of life of women. Most VVC is diagnosed and treated empirically and women frequently self-treat with over-the-counter medications that could contribute to an increase in the antifungal resistance. The effective treatment of RVVC has been a challenge in daily clinical practice. This review aims to assess the efficacy of antifungal agents administered orally or intravaginally for the treatment of RVVC, in order to define clinical

SUBMITTER: Lirio J 

PROVIDER: S-EPMC6537984 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature